The MHRA have released a Call for Evidence regarding the regulation of AI in healthcare. This evidence will then inform the recommendations of the National Commission into the Regulation of AI in Healthcare. The Commission is a body which brings together experts from technology, healthcare, law, patient groups, the public, government, and the NHS.
The MHRA is particularly keen to receive views from AI health tech companies and industry groups and will influence the development of a new regulatory framework for how AI is used in healthcare.
The National Commission wants to hear from everyone: whether you’re familiar with how AI is being used in healthcare or simply have thoughts about what rules should be in place to ensure it is properly regulated.
It invites evidence and views on:
- whether the UK’s framework for regulating AI in healthcare is sufficient
- how the UK’s regulatory framework may need to be improved to ensure fast access to safe and effective AI medical devices
- approaches to checking safety once AI medical devices are in use
- how responsibility and liability are managed between different parties involved in the deployment of AI medical devices.
This call for evidence can be found here. It closes at 11:59pm on 2 February 2026.
Please ensure you also send your submission to neil.plumridge@bivda.org.uk for inclusion in BIVDA’s sector-wide response.
If you have an enquiry relating to the policy content of the Call for Evidence, you can contact the MHRA by email at info@mhra.gov.uk with the subject line “National Commission into the Regulation of AI in Healthcare”.
